New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies

Rodriguez J.; Aran, VJ; Boiani, L; Olea Azar C.; Lavaggi, ML; Gonzalez, M.; Cerecetto, H.; Maya, JD; Carrasco-Pozo, C; Cosoy, HS

Abstract

New 5-nitroindazole derivatives were developed and their antichagasic properties studied. Eight compounds (14-18, 20, 26 and 28) displayed remarkable in vitro activities against Trypanosoma cruzi (T. cruzi). Its unspecific cytotoxicity against macrophages was evaluated being not toxic at a concentration at least twice that of T. cruzi IC 50, for some derivatives. The electrochemical studies, parasite respiration studies and ESR experiment showed that 5-nitroindazole derivatives not be able to yield a redox cycling with molecular oxygen such as occurs with nifurtimox (Nfx). The study on the mechanism of action proves to be related to the production of reduced species of the nitro moiety similar to that observed with benznidazole. © 2009 Elsevier Ltd. All rights reserved.

Más información

Título según WOS: New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies
Título según SCOPUS: New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies
Título de la Revista: BIOORGANIC & MEDICINAL CHEMISTRY
Volumen: 17
Número: 24
Editorial: PERGAMON-ELSEVIER SCIENCE LTD
Fecha de publicación: 2009
Página de inicio: 8186
Página final: 8196
Idioma: English
URL: http://linkinghub.elsevier.com/retrieve/pii/S0968089609009572
DOI:

10.1016/j.bmc.2009.10.030

Notas: ISI, SCOPUS